Pfizer Inc and BioNTech could secure emergency US and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side...
https://ift.tt/eA8V8J
from NDTV News - Topstories https://ift.tt/2INuQfK
https://ift.tt/eA8V8J
from NDTV News - Topstories https://ift.tt/2INuQfK
Comments
Post a Comment